Abstract:We report on adsorption and release of the anticancer drugs cisplatin and transplatin from mesoporous silica nanomaterials, emphasizing the differences between cisplatin and its much less toxic isomer. Two types of particles, MCM-41 and SBA-15, were used, either as just synthesized or after calcination to remove the templates. The particles were characterized by TEM, nitrogen physisorption, and elemental analysis. The UV-vis spectra of cisplatin and transplatin were obtained and the intensities of several bands (205-210 nm, 210-220 nm, 220-235 nm, and 300-330 nm) were found proportional to drug concentrations, allowing their use for measuring drug concentration. To evaluate drug adsorption by nanoparticles, nanoparticles were incubated in drug solutions and removed by centrifugation, after which the supernatants were scanned by spectrometer to determine drug remaining. It was found that calcined MCM adsorbed less cisplatin or transplatin per particle than as-synthesized MCM. SBA nanoparticles adsorbed slightly more cisplatin than MCM, and slightly less transplatin. Measurements of drug adsorption as a function of time show that drug is rapidly adsorbed by all particles studied. This rapid adsorption is probably associated with adsorption of drug on the external surfaces of the particles as well as the possible physisorption within the surfactant assemblies or by replacing the surfactant molecules or ions in the case of the as-synthesized materials. For calcined SBA particles, it is followed by a slow take-up of drug, perhaps due to the internal pores. There is no slow take-up by as-synthesized SBA particles or by either as-synthesized or calcined MCM particles. Measurement of the release of platinum drugs from nanoparticles previously soaked in drug solutions showed a substantial quick release for all particles and both drugs. This was followed by a slow release of Pt species in the case of transplatin in calcined SBA.

Preparation and in vitro Release of Nano-carbon Suspension Containing Cisplatin

Influence of Different Conjugated Proteins on Physical and Chemical Properties of Cisplatin-loaded Plu-Chol Niosomes

Novel nanoparticles of cisplatin:in vitro and in vitro antitumor activity

Novel nanoparticles of cisplatin:Preparation and study of properties

Stepwise Encapsulation and Controlled Two-Stage Release System for Cis-Diamminediiodoplatinum

Pharmacokinetics of Cisplatin Packaged in a Nanometer Liposome

Developing a Highly Stable PLGA-mPEG Nanoparticle Loaded with Cisplatin for Chemotherapy of Ovarian Cancer.

Electrospun Poly(ε-caprolactone) Composite Nanofibers with Controlled Release of Cis -Diamminediiodoplatinum for a Higher Anticancer Activity

PREPARATION OF CISPLATIN COMPOSITE MICRO/NANOFIBERS AND ANTITUMOR ACTIVITY IN VITRO AGAINST HUMAN TUMOR Spc-a-1 CELLS

Isomer-Dependent Adsorption and Release of Cis- and Trans-platin Anticancer Drugs by Mesoporous Silica Nanoparticles

Studies on Niosomes As Drug Carriers of Cis-Platin

One-pot synthesis of mesoporous silica nanocarriers with tunable particle sizes and pendent carboxylic groups for cisplatin delivery.

Preparation of cisplatin multivesicular liposomes and release of cisplatin from the liposomes in vitro]

Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy.

Platinum-Incorporating Poly(N-vinylpyrrolidone)-poly(aspartic Acid) Pseudoblock Copolymer Nanoparticles for Drug Delivery.

Aquated cisplatin and heparin-pluronic nanocomplexes exhibiting sustainable release of active platinum compound and NCI-H460 lung cancer cell antiproliferation

MANUFACTURE AND EVALUATION OF CISPLATIN-LOADED THERMOSENSITIVE NANOPARTICLE

Progress of Cisplatin Pharmacokinetics Research

Preparation, Characterization of Hydrophilic and Hydrophobic Drug in Combine Loaded Chitosan/cyclodextrin Nanoparticles and in Vitro Release Study

Stearyl polyoxyethylene-grafted heparin nanogel for oral delivery of Cisplatin: enhanced drug loading capacity and anticancer efficacy

Preparation of cisplatin delivery calcium phosphate nanoparticles using poly(Pt(IV) prodrug) as the payload